Peripheral muscle wasting in chronic obstructive pulmonary disease -: Clinical relevance and mechanisms

被引:141
作者
Debigarté, R
Côté, CH
Maltais, F
机构
[1] Univ Laval, Ctr Pneumol, Hop Laval, Inst Univ Cardiol & Pneumol, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Laval, CHU Laval, Ctr Rech, Ste Foy, PQ, Canada
关键词
D O I
10.1164/ajrccm.164.9.2104035
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In this article, the concept that muscle wasting in COPD is in fact a state of cachexia was developed. Muscle wasting should be considered as a serious complication in COPD and other chronic illnesses with important implications for survival. Up to now, there is no effective treatment for this complication but optimism is warranted now that the understanding of the molecular mechanisms of cachexia has evolved. Research on muscle wasting is extremely active and this will eventually lead to the development of specific treatments for cachexia such as proteasome and cytokine inhibition or muscle growth factors. The clinical approach to cachexia in COPD and other chronic diseases should change dramatically in the near future. This is an exciting research area to follow.
引用
收藏
页码:1712 / 1717
页数:6
相关论文
共 58 条
[1]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[2]  
[Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1
[3]   Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD [J].
Baarends, EM ;
Schols, AMWJ ;
Westerterp, KR ;
Wouters, EFM .
THORAX, 1997, 52 (09) :780-785
[4]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[5]   Interleukin-1α (IL-1α) and tumor necrosis factor α (TNFα) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro [J].
Benbassat, CA ;
Lazarus, DD ;
Cichy, SB ;
Evans, TM ;
Moldawer, LL ;
Lowry, SF ;
Unterman, TG .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :209-215
[6]   Peripheral muscle weakness in patients with chronic obstructive pulmonary-disease [J].
Bernard, S ;
LeBlanc, P ;
Whittom, F ;
Carrier, G ;
Jobin, J ;
Belleau, R ;
Maltais, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :629-634
[7]   Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants [J].
Buck, M ;
Chojkier, M .
EMBO JOURNAL, 1996, 15 (08) :1753-1765
[8]   Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease - A prospective, randomized, controlled study [J].
Burdet, L ;
deMuralt, B ;
Schutz, Y ;
Pichard, C ;
Fitting, JW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1800-1806
[9]  
Busquets S, 2000, J CELL PHYSIOL, V184, P380, DOI 10.1002/1097-4652(200009)184:3<380::AID-JCP13>3.0.CO
[10]  
2-F